DK1434570T3 - Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin - Google Patents

Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin

Info

Publication number: DK1434570T3
Authority: DK; Denmark
Prior art keywords: tetrahydroisoquinol; methanesulfonamido; quinazoline; dimethoxy; pyridyl
Prior art date: 2001-10-11

Application number

DK02775048T

Other languages

Danish (da)

English (en)

Inventor

John D Davis

Michael J Humphrey

Ross J Macrae

Janet S Smith

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-11

Filing date

2002-09-30

Publication date

2005-11-07

2002-09-30 Application filed by Pfizer filed Critical Pfizer

2005-11-07 Application granted granted Critical

2005-11-07 Publication of DK1434570T3 publication Critical patent/DK1434570T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

DK02775048T 2001-10-11 2002-09-30 Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin DK1434570T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0124455.7A GB0124455D0 (en)	2001-10-11	2001-10-11	Pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
DK1434570T3 true DK1434570T3 (da)	2005-11-07

Family

ID=9923660

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02775048T DK1434570T3 (da)	2001-10-11	2002-09-30	Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin

Country Status (33)

Country	Link
EP (1)	EP1434570B8 (fr)
JP (1)	JP4131471B2 (fr)
KR (1)	KR20050032510A (fr)
CN (1)	CN1568180A (fr)
AP (1)	AP2004003001A0 (fr)
AR (1)	AR036782A1 (fr)
AT (1)	ATE303135T1 (fr)
BR (1)	BR0213196A (fr)
CA (1)	CA2461168A1 (fr)
CO (1)	CO5560534A2 (fr)
DE (1)	DE60205925T2 (fr)
DK (1)	DK1434570T3 (fr)
DO (1)	DOP2002000464A (fr)
EA (1)	EA006168B1 (fr)
ES (1)	ES2246017T3 (fr)
GB (1)	GB0124455D0 (fr)
GT (1)	GT200200184A (fr)
HR (1)	HRP20040261A2 (fr)
HU (1)	HUP0600064A3 (fr)
IL (1)	IL160969A0 (fr)
IS (1)	IS7179A (fr)
MA (1)	MA27075A1 (fr)
MX (1)	MXPA04003293A (fr)
NO (1)	NO20041520L (fr)
OA (1)	OA12709A (fr)
PA (1)	PA8556001A1 (fr)
PE (1)	PE20030551A1 (fr)
PL (1)	PL369666A1 (fr)
PY (1)	PY0223360A (fr)
SV (1)	SV2004001279A (fr)
UY (1)	UY27477A1 (fr)
WO (1)	WO2003032956A1 (fr)
ZA (1)	ZA200401976B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0317663D0 (en) *	2003-07-29	2003-09-03	Astrazeneca Ab	Pharmaceutical composition
SG11201507258PA (en)	2013-03-14	2015-10-29	Amgen Inc	Heterocyclic compounds and their uses
KR101943592B1 (ko)	2017-08-31	2019-01-30	조현우	데이터 마이닝 기법을 이용한 전자가계부 시스템

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2053120T3 (es) *	1990-07-02	1994-07-16	Bend Res Inc	Perlas microporosas asimetricas para liberacion controlada.
FR2752737B1 (fr) *	1996-08-29	1998-10-02	Synthelabo	Comprime a liberation controlee de chlorhydrate d'alfuzosine
GB9700504D0 (en) *	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds
IL141235A (en) *	2000-02-09	2012-04-30	Novartis Int Pharm Ltd	Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
IL150634A0 (en) *	2000-03-03	2003-02-12	Pfizer	4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylate and polymorphs

2001
- 2001-10-11 GB GBGB0124455.7A patent/GB0124455D0/en not_active Ceased
2002
- 2002-09-12 DO DO2002000464A patent/DOP2002000464A/es unknown
- 2002-09-17 GT GT200200184A patent/GT200200184A/es unknown
- 2002-09-25 PY PY200200223360A patent/PY0223360A/es unknown
- 2002-09-30 HU HU0600064A patent/HUP0600064A3/hu unknown
- 2002-09-30 WO PCT/IB2002/004040 patent/WO2003032956A1/fr not_active Ceased
- 2002-09-30 BR BR0213196-0A patent/BR0213196A/pt not_active IP Right Cessation
- 2002-09-30 CA CA002461168A patent/CA2461168A1/fr not_active Abandoned
- 2002-09-30 HR HR20040261A patent/HRP20040261A2/hr not_active Application Discontinuation
- 2002-09-30 IL IL16096902A patent/IL160969A0/xx unknown
- 2002-09-30 AP APAP/P/2004/003001A patent/AP2004003001A0/en unknown
- 2002-09-30 KR KR1020047005316A patent/KR20050032510A/ko not_active Ceased
- 2002-09-30 EP EP02775048A patent/EP1434570B8/fr not_active Expired - Lifetime
- 2002-09-30 DK DK02775048T patent/DK1434570T3/da active
- 2002-09-30 PL PL02369666A patent/PL369666A1/xx not_active Application Discontinuation
- 2002-09-30 DE DE60205925T patent/DE60205925T2/de not_active Expired - Lifetime
- 2002-09-30 AT AT02775048T patent/ATE303135T1/de not_active IP Right Cessation
- 2002-09-30 ES ES02775048T patent/ES2246017T3/es not_active Expired - Lifetime
- 2002-09-30 EA EA200400431A patent/EA006168B1/ru not_active IP Right Cessation
- 2002-09-30 OA OA1200400094A patent/OA12709A/en unknown
- 2002-09-30 CN CNA02820042XA patent/CN1568180A/zh active Pending
- 2002-09-30 MX MXPA04003293A patent/MXPA04003293A/es active IP Right Grant
- 2002-09-30 JP JP2003535760A patent/JP4131471B2/ja not_active Expired - Fee Related
- 2002-10-09 PE PE2002000996A patent/PE20030551A1/es not_active Application Discontinuation
- 2002-10-09 AR ARP020103805A patent/AR036782A1/es unknown
- 2002-10-09 UY UY27477A patent/UY27477A1/es not_active Application Discontinuation
- 2002-10-10 SV SV2002001279A patent/SV2004001279A/es not_active Application Discontinuation
- 2002-10-10 PA PA20028556001A patent/PA8556001A1/es unknown
2004
- 2004-03-11 IS IS7179A patent/IS7179A/is unknown
- 2004-03-11 ZA ZA200401976A patent/ZA200401976B/en unknown
- 2004-03-18 CO CO04025929A patent/CO5560534A2/es not_active Application Discontinuation
- 2004-04-05 NO NO20041520A patent/NO20041520L/no unknown
- 2004-04-08 MA MA27623A patent/MA27075A1/fr unknown

Also Published As

Publication number	Publication date
DOP2002000464A (es)	2003-04-15
UY27477A1 (es)	2003-05-30
PE20030551A1 (es)	2003-06-26
AP2004003001A0 (en)	2004-03-31
IS7179A (is)	2004-03-11
ATE303135T1 (de)	2005-09-15
GB0124455D0 (en)	2001-12-05
CA2461168A1 (fr)	2003-04-24
JP4131471B2 (ja)	2008-08-13
GT200200184A (es)	2003-05-23
ES2246017T3 (es)	2006-02-01
MXPA04003293A (es)	2004-07-23
KR20050032510A (ko)	2005-04-07
EP1434570B1 (fr)	2005-08-31
EP1434570A1 (fr)	2004-07-07
IL160969A0 (en)	2004-08-31
DE60205925T2 (de)	2006-06-08
JP2005507909A (ja)	2005-03-24
WO2003032956A1 (fr)	2003-04-24
MA27075A1 (fr)	2004-12-20
BR0213196A (pt)	2004-08-31
HUP0600064A2 (en)	2006-06-28
DE60205925D1 (de)	2005-10-06
PL369666A1 (en)	2005-05-02
ZA200401976B (en)	2004-07-12
HUP0600064A3 (en)	2007-02-28
EA006168B1 (ru)	2005-10-27
SV2004001279A (es)	2004-02-19
NO20041520L (no)	2004-04-05
CO5560534A2 (es)	2005-09-30
HRP20040261A2 (en)	2004-08-31
CN1568180A (zh)	2005-01-19
EA200400431A1 (ru)	2004-08-26
OA12709A (en)	2006-06-26
AR036782A1 (es)	2004-10-06
EP1434570B8 (fr)	2005-10-26
PA8556001A1 (es)	2003-07-28
PY0223360A (es)	2004-04-01

Publication	Publication Date	Title
DK1292594T3 (da)	2004-12-06	Quinazolinderivater til behandling af tumorer
IS6524A (is)	2002-08-23	5-alkýlpyrídó(3-3-D)pyrimídín týrósín kínasa tálmar
IS7227A (is)	2004-04-19	Salt form af E-2-metoxí-N-(3-(4-(3-metýl-pýridín-3-yloxýl)-fenýlamínó)-kínasólín-6-yl)-allýl)-asetamíð, framleiðsla þess og notkun gegn krabbameini
ATE446093T1 (de)	2009-11-15	Substituierte chinazolin-derivate als aurora- kinase inhibitoren
DK1762567T3 (da)	2012-06-25	Pyrazolderivater til behandling af HIV
DK1417180T3 (da)	2007-04-10	Fremstilling af aminopyrimidinforbindelser
IS6968A (is)	2003-09-26	Nýir týrósínkínasa tálmar
DZ3425A1 (fr)	2002-03-21	Derives de quinolinone en tant qu'inhibiteurs kinases de tyrosine
DK1202746T3 (da)	2007-01-02	NSAID- og EGFR-kinaseinhibitorerholdigt præparat til behandling eller inhibering af colonpolypper og colorektal cancer
DK1259512T3 (da)	2003-12-29	Pteridinforbindelser til behandling af psoreasis
DK1408756T3 (da)	2008-06-02	Fremgangsmåde til bekæmpelse af ukrudt
NO20035540D0 (no)	2003-12-11	Eksoterme preparater til behandling av ektoparasitter
DK1458386T3 (da)	2007-08-13	Aroylpyrrolheteroaryl- og methanolforbindelser til behandling af en lidelse i centralnervesystemet
EE200300491A (et)	2004-02-16	6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena
DK1434570T3 (da)	2005-11-07	Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin
NO20024195D0 (no)	2002-09-03	4-amino-6,7-dimetoksy-2-(5-metansulfonamido-1,2,3,4- tetrahydroisoquinol-2-yl)-5-(2-pyridinyl)quinazolin-mesylat samtpolymorfer
DK1244359T3 (da)	2005-05-09	Kombination af fluazuron og ivermectin til kontrol af parasitter
DK1363928T3 (da)	2005-12-12	Fremgangsåde til fremstilling af (E)-5-(2-bromvinyl)-2'-deoxyuridin
DK1345605T3 (da)	2005-10-10	Varmformet lægemiddelsammensætning til styret afgivelse af perindopril
DK1534672T3 (da)	2013-07-29	Retinolderivater, deres anvendelse til behandling af cancer og til potensering af virkningen af andre cytotoksi¬ske midler
DK1153015T3 (da)	2005-02-07	Pyrimidin-2,4,6-trioner som inhibitorer af matrix-metalloproteinaser